The Company is moving its corporate headquarters and manufacturing operations from Anaheim to Tustin, California. 

BioPhotas, Inc., the maker of the Celluma Series of light therapy devices, is moving its corporate headquarters and manufacturing operations from Anaheim to Tustin, California. 

The new headquarters boasts 25,000 square feet of office and warehouse space, facilitating continued growth throughout 2023 and beyond. This added space allows BioPhotas to increase production and streamline shipping operations related to increased international sales. The Company will be fully operational in their new facilities on March 13, 2023.

“This provides the capacity needed to continue executing on our growth plans and provides for accelerating scale anticipated over the next five years,” says Patrick Johnson, Chief Executive Officer of BioPhotas, in a news release. “The benefits of light therapy in a number of explosive consumer segments including anti-aging, hair restoration and pain management are hitting a consumer awareness tipping point, and Celluma is positioned at the forefront as the LED light therapy innovation leader. It is also especially gratifying to be back in the City of Tustin where the company was founded 12 years ago.” 

This year has also seen a continued expansion of the Company’s international distribution network, with the addition of channel partners in Peru, Croatia, Denmark, Sweden, Finland, and Iceland. 

SOURCEModern Aesthetics
Previous articleSafest Soft Tissue Filler Injection Techniques
Next articleZemits released new electrode therapy treatment